$RLFTF Additional research... Mike Irwin @MikeIrw83705691

New Post Public Reply Private Reply Replies (0) Message Board
mc67
563
$RLFTF Additional research... Mike Irwin @MikeIrw83705691 on twitter found this paper regarding the application of VIP and makes the point that VIP is found throughout the body (not just the lungs) and has therapeutic effects beyond the lungs:

"In this review, we describe the pathology of several major neurological disorders and discuss the potential pharmacotherapeutic role of VIP and its receptors for the treatment of disorders such as Alzheimer’s disease, Parkinson’s disease, and Autism Spectrum Disorders."

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC...231918.pdf

- Uncle Gee Gee DD (copy)


by jtb3 Q. saw this posted on the RLFTF FB group... i need to verify the source

"The treatment of cancer patients can no longer be imagined without innovative immunotherapies. However, they also repeatedly lead to life-threatening inflammation of the lungs.

Scientists and doctors at the Freiburg University Medical Center have now successfully used a novel therapeutic approach on a patient. The patient had received immunotherapy for melanoma, also known as black skin cancer.

However, this triggered severe pneumonia. The doctors decided to give him the intestinal hormone “vasoactive intestinal peptide” (VIP) for inhalation, the use of which is being researched at the Freiburg University Medical Center for similar diseases.

The pneumonia disappeared completely within a few weeks, something that had not previously been possible with cortisone.

The case report was published on Jan.New England Journal of Medicine published."



Vasoactive Intestinal Peptide treats Respiratory Failure in COVID-19 by rescuing the Alveolar Type II cell Jonathan C. Javitt, MD, MPH

"VIP binds uniquely to receptors on Alveolar Type II cells in the lung, the same cells that bind the SARS-CoV-2 virus via their ACE2 receptors. VIP protects those cells and the surrounding pulmonary epithelium by blocking cytokines, preventing apoptosis, and upregulating the production of surfactant, the loss of which is increasingly implicated in COVID-19 respiratory failure."

https://www.authorea.com/users/321659/article...7ee4b95e20

AT2 cells are slow to grow, even in healthy lungs.
"In the normal lung, type II cells proliferate to provide daughter cells, some of which remain as type II cells and some of which transdifferentiate to become type I cells. The turnover of alveolar epithelial cells in the normal lung is slow and estimated to be in the order of 2–3 weeks."
Biology of alveolar type II cells

Tangentially, AT2 cells have been difficult to grow in the lab (in vitro), so studying them was difficult in the past.
Successful Establishment of Primary Type II Alveolar Epithelium with 3D Organotypic Coculture

There is no medical/scientific claim, or indication (yet anyway) that Aviptadil "repairs" the Alveolar Type II cells. Importantly, though, it arrests the further degradation of them giving the body a fighting chance to begin to replenish them (over several weeks).

We are all wishing Captain Searcy well, but since he was placed on Aviptadil, basically, at the "last minute", expectations of drastically improved chest xrays in a matter of a few days are not realistic. Such a situation (on "death bed" will probably turn out to be the exception, not the rule when it comes to Aviptadil. People in such dire conditions will most likely take week(s) to recover significant amounts of their AT2 cells. At least, that's what the outcomes look like with the data available at this time.

The fact that his chest xrays have not gotten worse is a good sign. It appears that the assault on his Alveolar Type II cells from Covid has been at least stopped.

He appears to be a fighter...a fighter who still has a ways to go.


Quote:
I know we are all wishing the best for him. Please understand that he was really bad off before RLF-100. Before RLF-100 was on the scene, he was on ECMO and was given 1 to 2 days to live.

- inelgr


Mondobiotech Holding AG Basel (RLFTF) Stock Research Links

RLFTF Board Company Profile Buy Rating Time & Sales News Filings Financials
$MJ
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 360

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 251

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 41

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 120

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 187

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 95

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 229

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 79

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading

Top 5 Most Recently Viewed Articles

Marqeta Class Action Lawsuit: Investor Rights Alert

Updated Category News Views 115

Investors Take Action: Marqeta, Inc. Securities Lawsuit In an important update for shareholders of Marqeta, Inc. (NASDAQ: MQ), it has been brought to attention by Kahn Swick & Foti, LLC that investors who have incurred losses exceeding $100,000 have until a specific deadline to file lead plaintiff applications in a key class action lawsuit. Understanding the Class Action...

Continue Reading
Emerging Strategies for the Chronic Refractory Cough Market

Updated Category News Views 266

Chronic Refractory Cough Market Overview The chronic refractory cough market is emerging as a significant opportunity for pharmaceutical companies. As analyzed, the market size is poised for considerable growth due to various factors, including rising disease prevalence and a corresponding increase in approved product availability. Notably, several innovative therapies...

Continue Reading
Hydreight Technologies: A Rising Star in Healthcare Services

Updated Category News Views 185

Hydreight Technologies Achieves Major Recognition In the fast-paced world of technology and healthcare, Hydreight Technologies Inc. has made an impressive mark, securing the spot of No. 77 on a prestigious list of the fastest-growing companies in North America. This ranking, part of the 2025 Deloitte Technology Fast 500™, positions Hydreight among elite innovators and...

Continue Reading
Empowering Communities: PHFA's $75 Million Housing RFP Launch

Updated Category News Views 90

Introducing the New PHARE Funding Opportunities for Housing The Pennsylvania Housing Finance Agency (PHFA) is excited to announce a new funding opportunity that aims to improve housing availability and affordability across the state. This initiative encourages organizations to submit proposals for projects designed to address urgent housing challenges in their...

Continue Reading
Investigating Investor Claims Against Polestar Automotive

Updated Category News Views 114

Investigation of Investor Claims Against Polestar Automotive Faruqi & Faruqi, LLP, a prominent national securities law firm, is initiating an investigation into potential claims for investors of Polestar Automotive Holding UK PLC. If you've experienced financial losses linked to Polestar, now is the time to explore your options and safeguard your rights. Understanding...

Continue Reading